Literature DB >> 22486734

QRISK or Framingham?

John Robson, Julia Hippisley-Cox, Carol Coupland.   

Abstract

Mesh：

Year:  2012        PMID： 22486734      PMCID： PMC3477356          DOI： 10.1111/j.1365-2125.2012.04293.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  5 in total

Review 1.  Cardiovascular risk.

Authors:  Rupert A Payne
Journal:  Br J Clin Pharmacol       Date:  2012-09       Impact factor: 4.335

2.  An independent and external validation of QRISK2 cardiovascular disease risk score: a prospective open cohort study.

Authors:  Gary S Collins; Douglas G Altman
Journal:  BMJ       Date:  2010-05-13

3.  Predicting cardiovascular risk in England and Wales: prospective derivation and validation of QRISK2.

Authors:  Julia Hippisley-Cox; Carol Coupland; Yana Vinogradova; John Robson; Rubin Minhas; Aziz Sheikh; Peter Brindle
Journal:  BMJ       Date:  2008-06-23

4.  Derivation and validation of QRISK, a new cardiovascular disease risk score for the United Kingdom: prospective open cohort study.

Authors:  Julia Hippisley-Cox; Carol Coupland; Yana Vinogradova; John Robson; Margaret May; Peter Brindle
Journal:  BMJ       Date:  2007-07-05

5.  An independent external validation and evaluation of QRISK cardiovascular risk prediction: a prospective open cohort study.

Authors:  Gary S Collins; Douglas G Altman
Journal:  BMJ       Date:  2009-07-07
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.